remdesivir
Washington (AFP) - The US Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19, after conditional authorization was given in May.Gilead said the drug, sold under the brand name Veklury, was the only specific treatment for Covid-19 approved so far under a more rigorous process.However, other treatments have received authorization for emergency use, though that approval can be revoked once the public health emergency sparked by the coronavirus pandemic is over.Other medications, like the steroid dex...
AFP
After being diagnosed with COVID-19 earlier this week, President Donald Trump is currently on Remdesivir, an antiviral drug made by Gilead Sciences. The drug has not yet been approved by the Food and Drug Administration, but it was authorized for emergency use in May for treating hospitalized patients with COVID-19. The president received his first IV infusion of the drug on Friday night, and doctors say that he will undergo a five-day treatment of the drug. In addition to Remdesivir, President Trump has also been given an infusion of Regeneron Pharmaceutical Inc.’s REGN-COV2 drug, zinc, vitam...
uPolitics.com
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら